Catalyst Wire Dossier Catalyst Wire Dossier

Futibatinib

futibatinib · Taiho Oncology, Inc.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Futibatinib, covering 2024-09-19 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy. [Phase 2, Phase 3]

See pricing